NIH Funding · FY2024
Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#13,137
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.1M across 2 grants · National rank #13137.
Top grants by award amount
Maksim Royzen's NIH grant portfolio, ranked by award amount.
- 2R44TR004026-02R44Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform$929.7Kaward amount
- 5R21HG012257-03R21Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification$193.9Kaward amount
Affiliations
Institutions that have administered grants for Maksim Royzen.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardTambo, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Multi-Institutional ResearchAwards at 2 institutions
Related investigators
Other NIH-funded PIs frequently associated with Maksim Royzen.
Explore further
Find collaborators for Maksim Royzen
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Tambo, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →